Dec 31, 2013

Neurocrine Biosciences Q4 2013 Earnings Report

Total Revenue
$730K
Previous year: $21.9M
-96.7%
EPS
-$0.16
Previous year: $0.14
-214.3%
Gross Profit
$730K
Previous year: $21.9M
-96.7%
Cash and Equivalents
$44.8M
Previous year: $63.8M
-29.7%
Free Cash Flow
-$11.1M
Previous year: -$8.95M
+23.7%
Total Assets
$155M
Previous year: $196M
-21.1%

Neurocrine Biosciences

Neurocrine Biosciences